We provide you with the best medicine purchasing service

Quickly morph client-centric results through performance based applications. Proactively facilitate professional human capital for cutting-edge.

Download Now

img

Agalsidase-beta (Fabrazyme®)

Fabry disease

1mg/kg every 2 weeks as IV infusion over 2-4 hours.(1, 3)

5 mg and 35 mg single-use vials for reconstitution to yield (5mg/mL).

IV

Infusion reaction consisted of one or more of the following: chills, fever, feeling hot or cold, dyspnea, nausea, flushing, headache, vomiting, paresthesia, fatigue, pruritus, pain in extremity, hypertension, chest pain, throat tightness, abdominal pain, dizziness, tachycardia,

nasal congestion, diarrhea, edema peripheral, myalgia, back pain, pallor, bradycardia, urticaria, hypotension, face edema, rash, and somnolence.

1b

1. Scriver CR. The metabolic & molecular bases of inherited disease. 8th ed. New York ; London: McGraw-Hill, 2001.

3. Wilcken B. Rare diseases and the assessment of intervention: what sorts of clinical trials can we use? J Inherit Metab Dis 2001;24(2):291-8

footer shape